| Literature DB >> 30781736 |
Zhuo Chen1, Dan Zhang2, Jia-Jia Guo3, Wei Tao4, Rui-Xue Gong5, Ling Yao6, Xing-Long Zhang7, Wei-Guo Cao8,9.
Abstract
Hawk tea is a rich and edible resource, traditionally used as a beverage in South China. This drink has many pharmacologic effects, such as acting as an antioxidant and reducing blood sugar and lipids. The objective of this work was to explore the active compound contents, bioactivities and their monthly changes, and optimize the harvest time. In the present study, Hawk tea from each month in 2017 was collected and extracted with 70% (v/v) ethanol. The contents of the total flavonoids and total phenols were determined using the colorimetric method. We determined the contents of seven characteristic active substances-hyperin, isoquercitrin, trifolin, quercitrin, astragalin, quercetin, and kaempferol-using high-performance liquid chromatography. The crude extract was tested for its antioxidant and inhibitory properties on enzymes involved in metabolic syndrome. Specifically, 2,2-diphenyl-1-picrylhydrazyl, 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid), ferric-reducing power assay, and the inhibition capacity test on α-glucosidase and lipase were conducted to determine the antioxidant effect in vitro, as well as the reduction of blood sugar and lipids. Monthly variations in activities and components were determined by numeric analysis and comparison. Correlation analysis revealed that antioxidant effects are significantly correlated with the total flavonoids. The hierarchical cluster analysis of bioactivities and their contents indicates that October and November are the best harvesting months, which differs with the habitual collection of Hawk tea.Entities:
Keywords: Hawk tea; active components; antioxidant; monthly variation; α-glucosidase and lipase
Mesh:
Substances:
Year: 2019 PMID: 30781736 PMCID: PMC6413118 DOI: 10.3390/molecules24040657
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Total flavonoids and total phenols contents of samples from twelve months.
| Month | Total Flavonoids (RE mg/g DW) | Total Phenolic Acids (GAE mg/g DW) |
|---|---|---|
| January | 8.00 ± 0.48 cd | 12.37 ± 0.44 e |
| February | 8.40 ± 0.91 cd | 14.50 ± 1.13 d |
| March | 9.53 ± 0.32 bc | 14.99 ± 0.67 d |
| April | 9.31 ± 0.51 bc | 17.17 ± 0.72 c |
| May | 7.40 ± 0.88 d | 12.97 ± 0.22 e |
| June | 6.79 ± 0.29 d | 12.51 ± 0.41 e |
| July | 8.86 ± 0.55 c | 16.51 ± 0.15 c |
| August | 6.91 ± 0.38 d | 21.92 ± 1.87 a |
| September | 10.14 ± 0.60 b | 18.97 ± 0.12 b |
| October | 11.75 ± 0.65 a | 16.53 ± 0.28 c |
| November | 11.57 ± 0.83 a | 19.89 ± 0.78 b |
| December | 6.50 ± 0.48 d | 10.91 ± 0.5 f |
Values are expressed as mean ± standard deviation; different superscript lowercase letters denote statistically significant difference (p < 0.05).
Figure 1High performance liquid chromatography profile of tea extract from Nov at 350 nm.
Contents of hyperin, isoquercitrin, quercitrin and astragalin, quercetin and kaempferol of different samples (in μg/g).
| Month | Hyperin | Isoquercitrin | Trifolin | Quercitrin/Astragalin | Quercetin | Kaempferol | Total Contents |
|---|---|---|---|---|---|---|---|
| Jan | 35.98 | 90.67 | 17.57 | 232.63 | 6.96 | 7.48 | 391.29 |
| Feb | 28.59 | 102.62 | 17.58 | 401.43 | 5.83 | 7.99 | 564.04 |
| Mar | 41.97 | 104.1 | 20.49 | 269.80 | 5.73 | 7.80 | 449.89 |
| Apr | 32.64 | 90.86 | 14.82 | 311.28 | 5.62 | 8.26 | 463.48 |
| May | 31.82 | 80.28 | 17.91 | 301.28 | 5.55 | 8.86 | 445.7 |
| Jun | 28.63 | 93.85 | 18.77 | 369.04 | 5.62 | 6.21 | 522.12 |
| Jul | 43.66 | 102.95 | 22.91 | 346.20 | 6.56 | 4.33 | 526.61 |
| Aug | 29.48 | 87.27 | 15.59 | 354.27 | 5.38 | 15.62 | 507.61 |
| Sep | 42.01 | 137.35 | 17.24 | 461.90 | 5.57 | 9.19 | 673.26 |
| Oct | 36.36 | 104.7 | 21.65 | 379.85 | 5.82 | 12.73 | 561.11 |
| Nov | 49.11 | 122.99 | 45.43 | 447.32 | 11.01 | 26.57 | 702.43 |
| Dec | 32.97 | 86.02 | 20.33 | 277.99 | 9.39 | 17.34 | 444.04 |
Calibration curve, LOD and LOQ, and linear range for six standards.
| Analytes | Regression Equation | R2 | LODs (μg/mL) | LOQs (μg/mL) | Linear Range (μg/mL) |
|---|---|---|---|---|---|
| Hyperin | y = 19587x − 1811.5 | 1 | 0.09 | 0.278 | 0.32–206.3 |
| Isoquercitrin | y = 19291x − 1922 | 1 | 0.09 | 0.27 | 0.43–273.8 |
| Trifolin | y = 16353x − 2087.6 | 1 | 0.09 | 0.26 | 0.57–362.5 |
| Quercitrin/Astragalin | y = 19270x − 2705.2 | 1 | 0.11 | 0.33 | 0.47–302.5 |
| Quercetin | y = 24303x − 6535.9 | 0.9999 | 0.18 | 0.53 | 0.39–252.5 |
| Kaempferol | y = 29685x − 2772.3 | 0.9999 | 0.06 | 0.18 | 0.20–126.3 |
DPPH, ABTS assays results (in mg/mL) of Hawk tea from 12 months.
| Month | DPPH | ABTS |
|---|---|---|
| January | 0.21 ± 0.001 g | 3.14 ± 0.03 e |
| February | 0.19 ± 0.001 e | 2.80 ± 0.07 d |
| March | 0.16 ± 0.005 d | 2.77 ± 0.01 d |
| April | 0.15 ± 0.003 c | 2.30 ± 0.01 d |
| May | 0.20 ± 0.003 f | 4.69 ± 0.03 g |
| June | 0.20 ± 0.006 f | 4.00 ± 0.18 f |
| July | 0.16 ± 0.006 d | 2.70 ± 0.09 d |
| August | 0.20 ± 0.003 f | 7.51 ± 0.29 h |
| September | 0.16 ± 0.008 d | 2.29 ± 0.07 bc |
| October | 0.15 ± 0.007 bc | 1.92 ± 0.02 bc |
| November | 0.14 ± 0.001 b | 2.05 ± 0.03 bc |
| December | 0.20 ± 0.008 f | 4.52 ± 0.18 g |
| BHT | 0.04 ± 0.001 a | 0.60 ± 0.01 a |
Values are expressed as mean ± standard deviation; different superscript lowercase letters denote statistically significant differences (p < 0.05).
Figure 2The absorbance variation of 12 sample solutions (5 mg/mL) in the radical reducing power reaction.
Results of inhibition on α-glucosidase and lipase.
| Month | α-Glucosidase | Lipase |
|---|---|---|
| January | 20.65 ± 0.19 k | 35.40 ± 0.23 cd |
| February | 14.72 ± 0.02 i | 33.06 ± 1.45 cd |
| March | 5.89 ± 0.29 b | 17.02 ± 2.65 b |
| April | 9.58 ± 0.03 e | 29.21 ± 1.41 cd |
| May | 8.19 ± 0.09 d | 32.72 ± 1.66 cd |
| June | 9.35 ± 0.06 e | 31.18 ± 1.52 d |
| July | 10.61 ± 0. 03 fg | 34.20 ± 0.42 d |
| August | 7.36 ± 0.37 c | 36.11 ± 2.41 d |
| September | 13.14 ± 0.05 h | 42.60 ± 1.32 e |
| October | 10.19 ± 0.29 f | 34.80 ± 1.46 d |
| November | 10.89 ± 0.05 g | 12.49 ± 0.81 b |
| December | 18.13 ± 0.02 j | 36.86 ± 1.24 de |
| Acarbose | 4.27 ± 0.17 a | ND |
| Orlistat | ND | 0.0006 a |
Values are expressed as mean ± standard deviation; different superscript lowercase letters denote statistically significant differences (p < 0.05).
The correlation between DPPH, ABTS, ferric reducing capacity with total flavonoids and total phenols.
| Component | DPPH | ABTS | Reducing Power |
|---|---|---|---|
| Total flavonoids | R2 = 0.916 ** | R2 = 0.935 ** | R2 = 0.955 ** |
| Total phenols | R2 = 0.504 | R2 = 0.238 | R2 = 0.417 |
** Extremely significant correlation, p < 0.01.
Figure 3Cluster analysis diagram based on ingredient contents and bioactivities.